AFT Pharmaceuticals (NZSE:AFT) Other Net Income (Loss) : NZ$0.0 Mil (TTM As of Sep. 2023)

View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Other Net Income (Loss)?

AFT Pharmaceuticals's Other Net Income (Loss) for the six months ended in Sep. 2023 was NZ$0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$0.0 Mil.

AFT Pharmaceuticals's annual Other Net Income (Loss) declined from Mar. 2021 (NZ$0.0 Mil) to Mar. 2022 (NZ$0.0 Mil) but then stayed the same from Mar. 2022 (NZ$0.0 Mil) to Mar. 2023 (NZ$0.0 Mil).

AFT Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for AFT Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Other Net Income (Loss) Chart

AFT Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Net Income (Loss)

Get a 7-Day Free Trial

AFT Pharmaceuticals Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Other Net Income (Loss)	Get a 7-Day Free Trial											-	-	-	-	-

AFT Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.0 Mil.

AFT Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

AFT Pharmaceuticals (NZSE:AFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (NZSE:AFT) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

AFP:Australia

Address

129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622

Website

https://www.aftpharm.com

AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.